Xiaoling Fu
Impact in
-
- Pharmacological Effects of Natural Compounds
Papers in
-
- Law, AI, and Intellectual Property 2
- Co-authors
- Qi Li (3 shared papers)Hua Sui (3 shared papers)Zhe‐Sheng Chen (2 shared papers)Huirong Zhu (3 shared papers)Lihong Zhou (1 shared paper)Jianping Huang (1 shared paper)Hao Wen (1 shared paper)Xuan Liu (1 shared paper)
- Journals
- Frontiers in Pharmacology (1 paper)Drug Resistance Updates (1 paper)Oncotarget (1 paper)Frontiers in Oncology (1 paper)Frontiers in Cell and Developmental Biology (1 paper)
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Xiaoling Fu
21 papers receiving 277 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 30
- Pharmacology 16
- Oncology 45
- Neurology 21
- Molecular Biology 91
Countries citing papers authored by Xiaoling Fu
This map shows the geographic impact of Xiaoling Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Fu more than expected).
Fields of papers citing papers by Xiaoling Fu
This network shows the impact of papers produced by Xiaoling Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Fu. The network helps show where Xiaoling Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 57 | |
| 2 | 2014 | 55 | |
| 3 | 2023 | 30 | |
| 4 | 2015 | 21 | |
| 5 | 2014 | 18 | |
| 6 | 2020 | 16 | |
| 7 | 2021 | 13 | |
| 8 | 2017 | 12 | |
| 9 | 2016 | 10 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 8 | |
| 13 | 2017 | 6 | |
| 14 | 2019 | 5 | |
| 15 | 2020 | 3 | |
| 16 | 2022 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 2021 | 2 | |
| 19 | 2023 | 1 | |
| 20 | 2023 | 1 |
About Xiaoling Fu
Xiaoling Fu is a scholar working on Artificial Intelligence, Molecular Biology, Oncology, Rheumatology and Psychiatry and Mental health, having authored 21 papers that have together received 280 indexed citations. Recurring topics across this work include Law, AI, and Intellectual Property (2 papers), Amyotrophic Lateral Sclerosis Research (1 paper), Head and Neck Cancer Studies (1 paper), Digital Media and Visual Art (1 paper), Amino Acid Enzymes and Metabolism (1 paper), Inflammatory mediators and NSAID effects (1 paper), Quinazolinone synthesis and applications (1 paper) and Blood groups and transfusion (1 paper). The work is most often cited by research in Cancer Research (30 citations), Pharmacology (16 citations), Oncology (45 citations), Neurology (21 citations) and Molecular Biology (91 citations). Xiaoling Fu has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Qi Li, Hua Sui, Zhe‐Sheng Chen, Huirong Zhu, Lihong Zhou, Jianping Huang, Hao Wen, Xuan Liu, Lihong Zhou and Huayue Zhang. Their work appears in journals such as Frontiers in Pharmacology, Drug Resistance Updates, Oncotarget, Frontiers in Oncology and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.